Research & Education
CURE Expert Connections
Email Sign Up
To start your customized experience click the start button
Customize your homepage by selecting specific cancer types.
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Side Effect Management
Small Lymphocytic Lymphoma (SLL)
Advocacy & Research
Share Your Story
Newsletter Sign Up
Ovarian Cancer Heroes
Bone Health Champions
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Ensuring an Accurate Lung Cancer Diagnosis Up Front
A discussion on the importance of obtaining a second opinion for any lung cancer diagnosis, whether at a cancer center of excellence, or at a community hospital.
The Spectrum of Outcomes for Small Cell Lung Cancer
Experts examine the large spectrum of outcomes for patients with small cell lung cancer, based on the aggressiveness of their disease.
Risk Factors That May Lead to Lung Cancer
Analysis of the environmental, biologic, and lifestyle risk factors associated with a higher susceptibility to lung cancer.
Varying Presentations of Patients With Lung Cancer
An overview of the varying presentations of patients suspected to have lung cancer, and the general workup to confirm a diagnosis.
Cure Expert Connections
Future Treatment Options for BRCA+ Breast Cancer
Concluding their discussion on PARP inhibition in BRCA+ breast cancer, the experts consider future directions for therapy in this setting.
Multidisciplinary Management of Breast Cancer
Kristin Fleischmann-Rose, NP, shares her perspective on the role of multidisciplinary care in treating patients with breast cancer.
BRCA+ Breast Cancer: Managing Patients on PARP Inhibitors
Experts share a focused discussion on how patients with BRCA+ breast cancer are managed while receiving PARP inhibition.
Benefit of PARP Inhibitors in BRCA+ Breast Cancer
Nadine Tung, M.D., and Kristin Fleischmann-Rose, NP, reflect on the value of PARP inhibition in patients with BRCA+ breast cancer.
Finding Emotional Support in a Health Care Team
Caitlin Cohen, M.S.N., RN, CPNP-AC, CPHON
The winner of the
® Extraordinary Healer® Award for Oncology Nursing discussed the bonds formed between patients with cancer and their health care team.
Giuliana Rancic: Finding the Light at the End of the Tunnel
Entertainment journalist and breast cancer survivor Giuliana Rancic shared her cancer journey before she presented at the 2019 Extraordinary Healer Award for Oncology Nursing.
Ovarian Cancer Treatments 'Coming Down the Pike' Create Resurgence for Patients
Shannon Westin, M.D., M.P.H.
An expert discusses the exciting new developments extending survival in the evolving ovarian cancer treatment space.
'Connection is Key' in Conversations Between Parents and Children About Ovarian Cancer
Ryan H. Mitstifer Walton
A young advocate emphasizes the importance of communication between parents and their children about an ovarian cancer diagnosis.
Not a member?
Sign up now!
Continue without login
OPTIONAL INFORMATION: The following information helps us tailor CURE to fit your needs
Please type below what best describes your interests and click on the selection(s):
I am a:
Please list other: